Page last updated: 2024-08-21

medroxyprogesterone and Hemoglobinopathies

medroxyprogesterone has been researched along with Hemoglobinopathies in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Altinoz, MA; Carin, MN; Gedikoglu, G; Ozdilli, K	1

Other Studies

1 other study(ies) available for medroxyprogesterone and Hemoglobinopathies

Article	Year
Medroxyprogesterone - valproic acid - aspirin. MVA regime to reduce transfusion associated mortality in late-term hemoglobinopathies. Hypothesis and rationale. Medical hypotheses, 2007, Volume: 68, Issue:6 Topics: Aspirin; Blood Transfusion, Intrauterine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Hemoglobinopathies; Humans; Medroxyprogesterone; Models, Biological; Pregnancy; Pregnancy Complications, Hematologic; Pregnancy Trimester, Third; Valproic Acid	2007

Article

Year

Medroxyprogesterone - valproic acid - aspirin. MVA regime to reduce transfusion associated mortality in late-term hemoglobinopathies. Hypothesis and rationale.

Medical hypotheses, 2007, Volume: 68, Issue:6

Topics: Aspirin; Blood Transfusion, Intrauterine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Hemoglobinopathies; Humans; Medroxyprogesterone; Models, Biological; Pregnancy; Pregnancy Complications, Hematologic; Pregnancy Trimester, Third; Valproic Acid

2007